ListedSMEPharmaceuticals & DrugsGOLDLINE
Goldline Pharmaceutical IPO
Goldline Pharmaceutical IPO is a sme IPO raising ₹12 Cr at ₹41 – ₹43 a share. It listed on 19 May 2026 and trades at ₹37 today, −13.0% against its issue price of ₹43. It was subscribed 0.00× in total.
₹43
Issue price
₹37
Price now
−13.0%
Since issue price
19 May 2026
Listed on
0.00×Subscribed (final) · all exchanges
No bids yet
populated partly populated we hold nothing here — the tab says why
Who bid for it
| Investor category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| Total | 0 | 0 | 0.00× |
Sub-categories read no separate quota rather than a dash: the exchange publishes bids at that level but never a reservation against them, so a subscription multiple does not exist — it is not missing data. Bids across both exchanges (NSE and BSE) — the figure usually quoted publicly. Last updated 25 Jul, 05:54 pm IST.
How demand built
Only one reading so far. We sample subscription every hour and store it whenever it moves, so this becomes a curve as bidding runs.